NEWS

The information contained in each news post on this page was factually accurate on the date it was issued and posted. 

“Unnatural Selection”

BioCentury, The Bernstein Report on BioBusiness January 10, 2011 issue article, "Unnatural Selection" in the Tools & Techniques section by BioCentury Senior Editor, Ms. Susan Schaeffer. Read More

read more

Sutro Biopharma Forges Partnership with Pfizer for Discovery, Development and Commercialization of Novel Peptide-Based Therapeutics. Company’s First Major Collaboration Validates Potential of Biochemical Protein Synthesis Technology Platform.

San Francisco, CA Jan. 7, 2011 - Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties, today announced that the company has entered into a multi-year collaboration with Pfizer for...

read more

Sutro Biopharma Secures $36.5 Million in Series C Financing

South San Francisco, CA Nov. 17, 2010 - Sutro Biopharma today announced that the company has secured $36.5 million in Series C financing. This financing will support the company's ongoing development of novel biotherapeutics with superior pharmaceutical properties and...

read more
Sutro Biopharma, Inc.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.